IBBvsSPDW
iShares Biotechnology ETF against SPDR Portfolio Developed World ex-US ETF — the fee, the flows, the book, and a year head-to-head.
Head to head
| IBB | SPDW | |
|---|---|---|
| Expense ratio | 0.44% | 0.030% |
| Assets | $11.1B | $41.6B |
| Net flow, 1 month | −$73M | +$917M |
| Net flow, 1 year | +$1.2B | +$5.3B |
| Return, YTD | +23.2% | +9.2% |
| Return, 1 year | — | — |
| Avg daily volume | 2M | 3.8M |
| Holdings | 243 | 2437 |
| Listed | Feb 5, 2001 | Apr 20, 2007 |
| Options market | Yes | Yes |
MARKED CELLS LEAD ON THAT LINE · LOWER FEE, LARGER ASSETS, STRONGER FLOWS & RETURNS